Prevalence of extrapulmonary tuberculosis and factors influencing successful treatment outcomes among notified cases in South India
Authors:
Top Cited Papers
Open Access
- 10 March 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Abstract
Tuberculosis (TB) remains a significant public health issue globally, with extra pulmonary tuberculosis (epTB) accounting for a considerable number of TB cases. This study aims to improve our understanding of epTB epidemiology by evaluating treatment outcomes and identifying factors associated with positive and negative treatment results in epTB patients. A retrospective study was conducted from January 1, 2016, to December 31, 2019. EpTB and rifampicin-resistant epTB were identified using the GeneXpert MTB/RIF assay. Logistic regression analysis was performed to determine the associated risk factors. Among the 4,526 patients with extra pulmonary tuberculosis, the positivity rate of Mycobacteriuum tuberculosis among the epTB was 16.5%, and the rate of rifampicin-resistant epTB was 4.83%. Most of patients had lymphadenitis TB (n = 348, 38.79%), followed by those with pus (n = 241, 31.95%). Of 746 epTB cases, 679 patients (91.02%) achieved successful treatment outcomes. Of the 36 patients with rifampicin-resistant epTB, 30 (83.3%) exhibited successful treatment outcomes. Tuberculous peritonitis (OR: 1.58), aspirate (OR: 1.59), gastric lavage (OR: 1.45), biopsy (OR: 1.73), Tuberculosis meningitis (TBM) (OR: 1.46), and tissue samples (OR: 3.33) were all significantly associated with unfavourable treatment outcomes. Patients with extrapulmonary tuberculosis (epTB) aged between 35 and 44 had a significantly higher likelihood of experiencing unsuccessful outcomes (OR = 1.79; 95% CI: 0.74–4.31, p = 0.0912). Additionally, individuals with a history of alcohol use showed a higher likelihood of poor outcomes (OR = 1.90; 95% CI: 0.25–14.42). Moreover, tuberculosis patients who used tobacco also had an increased likelihood of unfavourable treatment outcomes (OR = 2.62; 95% CI: 0.35–19.68).The study indicated that the rate of favourable treatment outcomes among epTB patients surpassed the World Health Organization’s target of ≥ 90%. However, a significant number of patients were lost to follow-up during treatment.Keywords
This publication has 30 references indexed in Scilit:
- Factors determining successful treatment outcome among notified tuberculosis patients in Belagavi district of North Karnataka, IndiaClinical Epidemiology and Global Health, 2024
- Epidemiology and factors associated with Extra-pulmonary tuberculosis in a Low-prevalence areaJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2023
- Impact of alcohol drinking and tobacco smoking on the drug-resistance of newly diagnosed tuberculosis: a retrospective cohort study in Shandong, China, during 2004–2020BMJ Open, 2022
- Risk factors associated with unsuccessful tuberculosis treatment outcomes in Hunan Province, ChinaTropical Medicine & International Health, 2022
- Assessment of burden of drug-resistant tuberculosis at a tertiary care centre in northern India: a prospective single centre cohort studyBMJ Open, 2021
- The trend of tuberculosis case notification and predictors of unsuccessful treatment outcomes in Samdrup Jongkhar district, Bhutan: A fourteen-year retrospective studyHeliyon, 2021
- Tuberculosis-Related Malnutrition: Public Health ImplicationsThe Journal of Infectious Diseases, 2019
- High mortality among tuberculosis patients on treatment in Nigeria: a retrospective cohort studyBMC Infectious Diseases, 2017
- Factors influencing treatment default among tuberculosis patients in a high burden province of South AfricaInternational Journal of Infectious Diseases, 2017
- Treatment outcome of smear-positive pulmonary tuberculosis patients in Tigray Region, Northern EthiopiaBMC Public Health, 2012